The American College of Obstetricians and Gynecologists has recently released updated clinical guidelines on breast cancer screening in women facing average risk.
The FDA converted Ibrance to regular FDA approval and approved a supplemental New Drug Application for the drug, broadening its range of antihormonal therapy.
The ABOG maintains the highest professional standards in Obstetrics, Gynecology, and Women's Health Care by establishing standards of evaluation to ensure the highest quality of care.
A new study gauges the absolute risk of major birth defects among infants exposed to second-generation antipsychotics during the first trimester of pregnancy to be 1.4%, compared with 1.1% for infants...
A randomized controlled trial found that subcutaneous fentanyl shows promise as an effective, safe alternative to intravenous administration for labor pain relief, with high maternal satisfaction and no...
Researchers conducted an international, multicenter, randomized noninferiority trial comparing radical hysterectomy with simple hysterectomy, including lymph-node assessment, in patients with low-risk...
